Synthesis, biological evaluation, and structure-activity relationships of N -benzoyl-2-hydroxybenzamides as agents active against P. falciparum (K1 strain), trypanosomes, and leishmania

Jozef Stec, Qingqing Huang, Marco Pieroni, Marcel Kaiser, Alina Fomovska, Ernest Mui, William H. Witola, Samuel Bettis, Rima McLeod, Reto Brun, Alan P. Kozikowski

Research output: Research - peer-reviewArticle

Abstract

In our efforts to identify novel chemical scaffolds for the development of new antiprotozoal drugs, a compound library was screened against Toxoplasma gondii tachyzoites with activity discovered for N-(4-ethylbenzoyl)-2- hydroxybenzamide 1a against T. gondii as described elsewhere. Synthesis of a compound set was guided by T. gondii SAR with 1r found to be superior for T. gondii, also active against Thai and Sierra Leone strains of Plasmodium falciparum, and with superior ADMET properties as described elsewhere. Herein, synthesis methods and details of the chemical analysis of the compounds in this series are described. Further, this series of N-benzoyl-2-hydroxybenzamides was repurposed for testing against four other protozoan parasites: Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Leishmania donovani, and P. falciparum (K1 isolate). Structure-activity analyses led to the identification of compounds in this set with excellent antileishmanial activity (compound 1d). Overall, compound 1r was the best and had activity 21-fold superior to that of the standard antimalarial drug chloroquine against the K1 P. falciparum isolate.

LanguageEnglish (US)
Pages3088-3100
Number of pages13
JournalJournal of Medicinal Chemistry
Volume55
Issue number7
DOIs
StatePublished - Apr 12 2012
Externally publishedYes

Fingerprint

Trypanosomiasis
Leishmania
Toxoplasma
Structure-Activity Relationship
2-hydroxybenzamide
Plasmodium falciparum
Trypanosoma brucei rhodesiense
Sierra Leone
Leishmania donovani
Trypanosoma cruzi
Chloroquine
Antimalarials
Libraries
Parasites
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Synthesis, biological evaluation, and structure-activity relationships of N -benzoyl-2-hydroxybenzamides as agents active against P. falciparum (K1 strain), trypanosomes, and leishmania. / Stec, Jozef; Huang, Qingqing; Pieroni, Marco; Kaiser, Marcel; Fomovska, Alina; Mui, Ernest; Witola, William H.; Bettis, Samuel; McLeod, Rima; Brun, Reto; Kozikowski, Alan P.

In: Journal of Medicinal Chemistry, Vol. 55, No. 7, 12.04.2012, p. 3088-3100.

Research output: Research - peer-reviewArticle

Stec, Jozef ; Huang, Qingqing ; Pieroni, Marco ; Kaiser, Marcel ; Fomovska, Alina ; Mui, Ernest ; Witola, William H. ; Bettis, Samuel ; McLeod, Rima ; Brun, Reto ; Kozikowski, Alan P./ Synthesis, biological evaluation, and structure-activity relationships of N -benzoyl-2-hydroxybenzamides as agents active against P. falciparum (K1 strain), trypanosomes, and leishmania. In: Journal of Medicinal Chemistry. 2012 ; Vol. 55, No. 7. pp. 3088-3100
@article{91fd1b2461224d9fb3535776ac241346,
title = "Synthesis, biological evaluation, and structure-activity relationships of N -benzoyl-2-hydroxybenzamides as agents active against P. falciparum (K1 strain), trypanosomes, and leishmania",
abstract = "In our efforts to identify novel chemical scaffolds for the development of new antiprotozoal drugs, a compound library was screened against Toxoplasma gondii tachyzoites with activity discovered for N-(4-ethylbenzoyl)-2- hydroxybenzamide 1a against T. gondii as described elsewhere. Synthesis of a compound set was guided by T. gondii SAR with 1r found to be superior for T. gondii, also active against Thai and Sierra Leone strains of Plasmodium falciparum, and with superior ADMET properties as described elsewhere. Herein, synthesis methods and details of the chemical analysis of the compounds in this series are described. Further, this series of N-benzoyl-2-hydroxybenzamides was repurposed for testing against four other protozoan parasites: Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Leishmania donovani, and P. falciparum (K1 isolate). Structure-activity analyses led to the identification of compounds in this set with excellent antileishmanial activity (compound 1d). Overall, compound 1r was the best and had activity 21-fold superior to that of the standard antimalarial drug chloroquine against the K1 P. falciparum isolate.",
author = "Jozef Stec and Qingqing Huang and Marco Pieroni and Marcel Kaiser and Alina Fomovska and Ernest Mui and Witola, {William H.} and Samuel Bettis and Rima McLeod and Reto Brun and Kozikowski, {Alan P.}",
year = "2012",
month = "4",
doi = "10.1021/jm2015183",
volume = "55",
pages = "3088--3100",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "7",

}

TY - JOUR

T1 - Synthesis, biological evaluation, and structure-activity relationships of N -benzoyl-2-hydroxybenzamides as agents active against P. falciparum (K1 strain), trypanosomes, and leishmania

AU - Stec,Jozef

AU - Huang,Qingqing

AU - Pieroni,Marco

AU - Kaiser,Marcel

AU - Fomovska,Alina

AU - Mui,Ernest

AU - Witola,William H.

AU - Bettis,Samuel

AU - McLeod,Rima

AU - Brun,Reto

AU - Kozikowski,Alan P.

PY - 2012/4/12

Y1 - 2012/4/12

N2 - In our efforts to identify novel chemical scaffolds for the development of new antiprotozoal drugs, a compound library was screened against Toxoplasma gondii tachyzoites with activity discovered for N-(4-ethylbenzoyl)-2- hydroxybenzamide 1a against T. gondii as described elsewhere. Synthesis of a compound set was guided by T. gondii SAR with 1r found to be superior for T. gondii, also active against Thai and Sierra Leone strains of Plasmodium falciparum, and with superior ADMET properties as described elsewhere. Herein, synthesis methods and details of the chemical analysis of the compounds in this series are described. Further, this series of N-benzoyl-2-hydroxybenzamides was repurposed for testing against four other protozoan parasites: Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Leishmania donovani, and P. falciparum (K1 isolate). Structure-activity analyses led to the identification of compounds in this set with excellent antileishmanial activity (compound 1d). Overall, compound 1r was the best and had activity 21-fold superior to that of the standard antimalarial drug chloroquine against the K1 P. falciparum isolate.

AB - In our efforts to identify novel chemical scaffolds for the development of new antiprotozoal drugs, a compound library was screened against Toxoplasma gondii tachyzoites with activity discovered for N-(4-ethylbenzoyl)-2- hydroxybenzamide 1a against T. gondii as described elsewhere. Synthesis of a compound set was guided by T. gondii SAR with 1r found to be superior for T. gondii, also active against Thai and Sierra Leone strains of Plasmodium falciparum, and with superior ADMET properties as described elsewhere. Herein, synthesis methods and details of the chemical analysis of the compounds in this series are described. Further, this series of N-benzoyl-2-hydroxybenzamides was repurposed for testing against four other protozoan parasites: Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Leishmania donovani, and P. falciparum (K1 isolate). Structure-activity analyses led to the identification of compounds in this set with excellent antileishmanial activity (compound 1d). Overall, compound 1r was the best and had activity 21-fold superior to that of the standard antimalarial drug chloroquine against the K1 P. falciparum isolate.

UR - http://www.scopus.com/inward/record.url?scp=84859798409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859798409&partnerID=8YFLogxK

U2 - 10.1021/jm2015183

DO - 10.1021/jm2015183

M3 - Article

VL - 55

SP - 3088

EP - 3100

JO - Journal of Medicinal Chemistry

T2 - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 7

ER -